Dr. Mark A. Lerman
Dr. Mark A. Lerman is an associate professor in the Department of Diagnostic Sciences at the Tufts University School of Dental Medicine (TUSDM) and is the laboratory director of Tufts Oral Pathology Services (TOPS). Dr. Lerman graduated from TUSDM in 2002 and completed a one-year general practice residency at the Harvard School of Dental Medicine and Brigham and Women’s Hospital. After undergoing his oral pathology residency at New York Hospital Medical Center of Queens, New York, Dr. Lerman joined the full-time faculty at the Harvard School of Dental Medicine in 2006 and was appointed as a junior associate in surgery at Brigham and Women’s Hospital. He is a fellow of the American Academy of Oral and Maxillofacial Pathology and a board-certified diplomate of the American Board of Oral and Maxillofacial Pathology. Dr. Lerman is active in organized dentistry and his specialty’s national academy, and he has multiple publications in the medical and dental peer-reviewed literature on a variety of pathology subjects. Dr. Lerman practices clinical oral pathology at TUSDM and has delivered numerous invited continuing education courses and oral/poster presentations at regional, national, and international meetings and conferences.
Dr. Tanya A. Wright
Dr. Tanya A. Wright is an assistant professor in the Department of Diagnostic Sciences at the Tufts University School of Dental Medicine. Dr. Wright is a 2001 graduate of Meharry Medical College School of Dentistry and completed her oral pathology residency in 2004 at New York Hospital Medical Center of Queens, New York. Upon completion of her training, Dr. Wright was appointed as a full-time assistant professor at Meharry, serving in 2008-09 as interim Chair of the Department of Oral Diagnostic Sciences. She was selected as a member of the 2007 ADEA/AAL Institute for Teaching and Learning, and she earned a student choice award from the Dental Class of 2010. Dr. Wright is a Fellow of the American Academy of Oral and Maxillofacial Pathology and a Diplomate of the American Board of Oral and Maxillofacial Pathology, and she has delivered numerous invited lectures and continuing education courses. Dr. Wright’s research interests include salivary gland malignancies and salivary diagnostic testing.
Nora M. Laver, MD
Dr. Nora Laver is an associate professor in the Department of Ophthalmology at the Tufts University School of Medicine and in the department of Diagnostic Sciences at the Tufts University School of Dental Medicine. Dr. Laver is a graduate of the University of the Buenos Aires School of Medicine, Buenos Aires, Argentina and completed a residency in pathology at Georgetown University Medical Center, Washington, DC. She then completed a fellowship in cytopathology at Georgetown University Medical Center, and completed Callender-Binford Fellowships in ocular pathology and in oral and maxillofacial pathology, both at the Armed Forces Institute of Pathology, Washington D.C. In addition to directing ocular pathology at the New England Eye Center, she has served as Director of Pathology Residency Training, Director of Cytopathology, and Director of Head and Neck Pathology at the same institution. She is a consultant pathologist at Boston Medical Center Department of Pathology and Atrius Health – Harvard Vanguard Medical Associates. Dr. Laver has published over 50 medical peer-reviewed articles and 12 book chapters, has organized two head and neck cancer conferences, and has participated in numerous presentations and continuing education courses locally, regionally and internationally. Dr. Laver’s training and experience uniquely qualify her to evaluate head and neck pathology specimens. She is certified by the American Board of Pathology in anatomic pathology and cytopathology. She is available for consultation regarding the entire spectrum of head and neck pathology cases, including oral cytology, fine needle aspiration biopsies, tissue biopsies and resection specimens. Methods include standard histopathology, immunofluorescence studies, immunohistochemistry, in situ hybridization, flow cytometry, PCR, and electron microscopy studies.
Additional Research Faculty
Jonathan Garlick, DDS, PhD
Dr. Jonathan Garlick is Professor in the Department of Oral and Maxillofacial Pathology and Director of the Division of Cancer Biology and Tissue Engineering at Tufts University School of Dental Medicine. Dr. Garlick also holds appointments at Tufts University’s School of Medicine (Department of Anatomy and Cell Biology) and in the Department of Bioengineering and is a member of the Program in Cell, Molecular and Developmental Biology at Tufts.
He is a graduate of Stony Brook University’s School of Dental Medicine where he received his dental degree. He completed his residency training in Oral and Maxillofacial Pathology at Long Island Jewish Medical Center and received his Ph.D. from Stony Brook University through a Physicians-Scientist Award from the NIH.
Dr. Garlick remained at Stony Brook for 10 years, where he was Head of Oral Pathology and Oral Medicine. His expertise in the bioengineering of human skin equivalents has led him to establish the Center for Integrated Tissue Engineering (CITE) at Tufts as a resource for experimentation in three-dimensional (3D) human tissues. He has developed techniques for the bioengineering of human epithelial tissues to study the pathogenesis of a variety of oral and skin diseases. Dr. Garlick has used these tissues to study early cancer development and to add to the emerging understanding of cancer as a disease of altered tissue structure. These 3D bioengineered human tissues now serve as a platform technology for the pharmaceutical design and screening of drugs targeted for specific therapeutic applications to treat human cancer.
He has authored over 60 articles and book chapters on these subjects. On the national level, Dr. Garlick has served as Chair and as a member of several NIH grant review panels, is on the editorial board of several scientific journals and has chaired numerous national symposia. In 2000, he was awarded Stony Brook School of Dental Medicine’s Distinguished Alumnus Award in recognition of his local and national contributions to the dental profession. In 2001, he was awarded the President and Chancellor’s Award, the State University of New York’s highest teaching honor for his educational contributions in Oral Pathology and Oral Medicine to the students of Stony Brook University’s Dental School.
Contact Dr. Garlick at (617) 636-2444 or Jonathan.Garlick@tufts.edu.
William M. Morlang, DDS
William M. Morlang, D.D.S. is a forensic odontologist and disaster management consultant in San Antonio, Texas. He serves as a forensic consultant to the Armed Forces Medical Examiner, Armed Forces Institute of Pathology, and Air Force Office of Special Investigation. He is an adjunct Associate Professor, School of Dental Medicine, Tufts University. He is also a faculty member at the Armed Forces Institute of Pathology.
Dr. Morlang is a graduate of the University of Florida, West Virginia University, Armed Forces Staff College, National Defense University, and Inter-Agency Institute for Federal Healthcare Executives at George Washington University. He trained in oral pathology, forensic dentistry, aerospace pathology, and advanced forensic pathology at the Armed Forces Institute of Pathology and FBI Academy. He served in the U.S. Air Force from 1966 until 1996, earning the rank of colonel in 1979. He is a diplomate of the American Board of Forensic Odontology (ABFO) and served on the ABFO Board of Directors, ABFO Research Committee, ABFO Mass Disaster Committee, ABFO Bitemark Committee, and ABFO Certification and Examining Committee.
Dr. Morlang was the 1996 president of the American Society of Forensic Odontology (ASFO) and served on the ASFO Board of Governors. He is a fellow of the American Academy of Forensic Sciences, Academy of General Dentistry, American College of Dentists, and International College of Dentist. He is a member of the American College of Legal Medicine, American Academy of Oral and Maxillofacial Radiology, and American Dental Association.
His extensive experience in mass disaster management and identification of human remains includes: Big Thompson Canyon Flood, Pan Am/KLM 747 mishap, Jonestown Guyana tragedy, two LOT Polish Airline accidents, Arrow Airways mishap, Grenada assassinations, Battleship Iowa explosion, numerous military aircraft accidents and Vietnam war. Col. Morlang served as the Consultant in Forensic Dentistry to the USAF Surgeon General and was the first military officer to introduce bitemark evidence into federal court. Dr. Morlang is a recognized Total Quality Management leader and educator, and an experienced Malcolm Baldridge Quality Award evaluator. He has lectured internationally on forensic sciences, mass disaster management, and quality leadership. Dr. Morlang has written numerous forensic articles, syllabi, mass disaster management plans, and textbook chapters.
Contact Dr. Morlang at (210) 651-5848, or by email at firstname.lastname@example.org.
Naomi Rosenberg, PhD
In February 2004, Dr. Naomi Rosenberg was appointed the Dean of the Sackler School of Graduate Biomedical Sciences. She is also a Professor of Molecular and Microbiology at Tufts University School of Medicine and holds an academic appointment in the Department of Oral and Maxillofacial Pathology at Tufts University School of Dental Medicine. Dr. Rosenberg earned her A.B. Biology degree at Boston University and her Ph.D. from the University of Vermont. She completed postdoctoral training at the Massachusetts Institute of Technology in the mid-1970s and joined Tufts University at the Boston campus’ cancer research center in 1977 upon completion of that program. She was among Sackler’s first faculty when the school was created as part of the medical school in 1983. She helped develop and for years directed the school’s genetics program.
In her role as Dean, Dr. Rosenberg is responsible for the Ph.D. and related education training programs of the Sackler School. She also plays a key role working with the medical school Dean Michael Rosenblatt in strategic planning for research on the Health Sciences campus.
Currently, Dr. Rosenberg conducts research in the Department of Pathology investigating the ways cancer develops. She has achieved a distinguished record of achievement in her laboratory. For example, she developed the first tractable model to study leukemia development in vitro using Abelson murine leukemia virus, work that paved the way for identification of the abl oncogene and the discovery that this oncogene is responsible for human chronic myelogenous leukemia (CML). These discoveries were central to the development of imantinib, a drug used to treat CML. This model system also played a major role in experiments that led to understanding the basic process whereby genes are rearranged so that antibody molecules can be produced, a critical step in the immune response. Her lab continues to use a genetic approach to dissect the ways in which the Abl oncoprotein alters cell growth and has found that one important aspect of the process is blocking the natural death response of cells.
At the national level, Dr. Rosenberg has served on numerous federal committees and is presently a member of the Recombinant DNA Advisory Committee of the National Institutes of Health (NIH) and a member of the Board of Directors of the Leukemia and Lymphoma Society of America. Previously, she has served on the Board of Scientific Counselors of the National Cancer Institute of the NIH. Dr. Rosenberg has mentored 25 successful Ph.D. students and five others are currently training in her laboratory. She has been funded by the NIH continuously for 27 years.
Contant Dr. Rosenberg at (617) 636-2143 or email@example.com.
Christophe Egles, Ph.D.
Dr. Christophe Egles joined Tufts University in the Division of Cancer Biology and Tissue Engineering as an Assistant Professor in July 2005 and serves as the Associate Director of the Center for Integrated Tissue Engineering (CITE). Dr. Egles earned his B.S. in Biochemistry and his Ph.D. in Neurobiology at the University Louis Pasteur in Strasbourg, France. From 1998 to 2001, he was a postdoctoral fellow at the Massachusettes Institute of Technology and, later, at Tufts University School of Medicine studied the molecular and cellular mechanisms underlying synapse formation during early steps of neural development. From 2001 to 2004, he served as Associate Professor at the University Louis Pasteur, School of Dentistry, where he studied the biomedical applications of biomaterials modifying cell/support interface, particularly for regenerative neurobiology or antibacterial protection. At the Division of Cancer Biology and Tissue Engineering his research is focused on biofunctionalized artificial matrices, developing wound healing models and creating anti-microbial surfaces for the protection of medical devices.
Contact Dr. Egles at (617) 636-3405 or by email: firstname.lastname@example.org.
Pamela Yelick, Ph.D.
Pamela Crotty Yelick, Ph.D., is a Professor, at Tufts University, Boston MA, where she is the Director of the Division of Craniofacial and Molecular Genetics in the Department of Oral and Maxillofacial Pathology. Dr. Yelick holds adjunct appointments in the Departments of Bioengineering, Genetics, and Molecular and Cell Biology. Dr. Yelick received her B.A. in Biology from Smith College, Northampton MA in 1979, and her Ph.D. in Molecular Biology from Tufts University in 1989. She received her postdoctoral training at the Dana Farber Cancer Institute, Boston MA and the Harvard Biological Laboratories, Cambridge MA. Dr. Yelick’s major research interests are molecular genetic analyses of craniofacial cartilage, bone, and tooth development. Her research focuses on manipulating mammalian postnatal dental stem cells for whole tooth tissue engineering applications, and the zebrafish, Danio rerio, as a model for craniofacial development and tooth regeneration. She has received grant support from multiple funding agencies including RO3, R21, R41 and RO1 support from NIH/NIDCR, and Proof of Principle, and Application Development Awards from the Center for Innovative Medicine and Innovative Technologies (CIMIT).
Contact Dr. Yelick at (617)-636-2430 or by email at email@example.com.